Gene Mack - Net Worth and Insider Trading
Gene Mack Net Worth
The estimated net worth of Gene Mack is at least $27,792 dollars as of 2025-03-05. Gene Mack is the CFO and Interim CEO of Gain Therapeutics Inc and owns about 14,400 shares of Gain Therapeutics Inc (GANX) stock worth over $27,792. Details can be seen in Gene Mack's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gene Mack has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gene Mack
Gene Mack Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gene Mack owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .
Click here to see the complete history of Gene Mack’s form 4 insider trades.
Insider Ownership Summary of Gene Mack
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLS | SELLAS Life Sciences Group Inc | 2018-04-20 | CFO and Treasurer |
Gene Mack Latest Holdings Summary
Gene Mack currently owns a total of 1 stock. Gene Mack owns 14,400 shares of Gain Therapeutics Inc (GANX) as of August 9, 2024, with a value of $27,792.
Latest Holdings of Gene Mack
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2024-08-09 | 14,400 | 1.93 | 27,792 |
Holding Weightings of Gene Mack
Gene Mack Form 4 Trading Tracker
According to the SEC Form 4 filings, Gene Mack has made a total of 1 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 14,400 shares on August 9, 2024, which cost Gene Mack around $14,544.
Insider Trading History of Gene Mack
- 1
Gene Mack Trading Performance
GuruFocus tracks the stock performance after each of Gene Mack's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gene Mack is 125.7%. GuruFocus also compares Gene Mack's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gene Mack within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gene Mack's insider trading performs compared to the benchmark.
Performance of Gene Mack
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.2 |  | | | | |
| Relative Return to S&P 500(%) | 15.83 | | | | | |
Gene Mack Ownership Network
Ownership Network List of Gene Mack
Ownership Network Relation of Gene Mack
Gene Mack Owned Company Details
What does SELLAS Life Sciences Group Inc do?
Who are the key executives at SELLAS Life Sciences Group Inc?
Gene Mack is the CFO and Treasurer of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .
SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SELLAS Life Sciences Group Inc Insider Transactions
Gene Mack Mailing Address
Above is the net worth, insider trading, and ownership report for Gene Mack. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gene Mack's mailing address is: New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
